Zantac and Generic Ranitidine Heartburn Medicine Recalled Because of Cancer Link

Zantac has garnered headlines leading to all generic ranitidine medications being recalled

Monday, July 13, 2020 - The world's best-selling Heartburn and acid-reflux medicine Zantac was recalled over concerns that it is chemically unstable and could cause stomach, bladder, intestinal, and many other forms of cancer. Thousands of cancer sufferers or the estates of those who have died have consulted a Zantac Cancer Lawyer have or expected to file lawsuits against Sanofi, the maker of the drug for failing to warn consumers of what they knew or had a responsibility to know about the drug's high NDMA defect. The number of lawsuits could grow into substantial personal injury litigation in 2020 and beyond as plaintiffs allege that Sanofi purposefully hid the drug's alleged cancer-causing complications. Others are suffering in the wake of the Zantac recall in addition to those who are suffering from cancer.

Millions of heartburn sufferers are no longer able to find their preferred acid reflux relief drug, and are also afraid to take Zantac's alternatives over concerns about protein pump inhibitor drugs (PPIs) may increase a person's risk of developing severe symptoms from the Coronavirus. Stomach acids kill unwanted bacteria and viruses, and heartburn drugs block the production of stomach acid.

On April 1, 2020, the US Food and Drug Administration (FDA) took decisive action to prevent the use or prescription of the entire class of ranitidine heartburn medications. The American Journal of Managed Care writes. "The FDA has requested all ranitidine (Zantac) products be pulled from the market immediately, according to a statement. The recall includes all prescription and over-the-counter ranitidine drugs as ongoing investigations uncovered levels of N-Nitrosodimethylamine (NDMA), a probable human carcinogen, increase over time." In addition to popular brand name drugs like Zantac, Pepcid, and Prilosec that have garnered media attention, other generic ranitidine heartburn drugs have been recalled and their prescription forbidden in the FDA's most recent directive.

Over the counter drug manufacturer, Apotex Corp. has recalled all of their generic 75 mg and 150 mg ranitidine tablets sold in retail pharmacies Walgreens, Walmart and Rite-Aid over the fear that high storage temperatures could cause ranitidine to become unstable and increase the levels of NDMA, a known carcinogen. According to an investigative report at KXAN Austin, other ranitidine manufacturers that have pulled their generic heartburn medicines include, "Novartis-owned Sandoz recall(ing their) 30-count, 50-count and 500-count bottles of prescription ranitidine capsules, and overseas, British drugmaker GlaxoSmithKline, recalling ranitidine products in India and Hong Kong (it does not sell versions of the drug in the US). Several countries are taking steps to restrict sales of drugs containing ranitidine." The FDA has a complete list on their website which includes the following generic ranitidine tablets: all sizes of USP 150mg- acid reducer sold at Rite Aid and Walmart, and Walgreen's, "Wal-Zan 150 RANITIDINE TABLETS, USP 150 mg / ACID REDUCER."

If you or a loved one have taken Zantac regularly and has developed stomach, bladder, prostate, esophageal, intestinal, colon, breast, liver, or other cancer, you may qualify to file a claim against Sanofi, the drug's manufacturer.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.